Eosinophilic hepatitis in an adolescent during lisdexamfetamine dimesylate treatment for ADHD.


We describe here the case of an adolescent who developed eosinophilic hepatitis during treatment for attention-deficit/hyperactivity disorder with lisdexamfetamine dimesylate (Vyvanse [Shire US Inc, Wayne, PA]). A 14-year-old boy presented to his primary care provider with abdominal pain and worsening jaundice. A diagnosis of hepatitis was made with… (More)
DOI: 10.1542/peds.2009-1835

1 Figure or Table


  • Presentations referencing similar topics